-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Calidi Biotherapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2022 to 2024.
- Calidi Biotherapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$7.13M, a 86.1% decline year-over-year.
- Calidi Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$19.7M, a 27% increase from 2023.
- Calidi Biotherapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$27M, a 104% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)